{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "10",
                "@year": "2020",
                "@timestamp": "2020-02-10T17:04:20.000020-05:00",
                "@month": "02"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2018",
                "@month": "10"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding-addon-generated-timestamp": "2021-02-03T20:34:28.986015Z",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Pharmacy Practice"},
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113044315"
                            },
                            "@dptid": "113044315"
                        },
                        "author": [
                            {
                                "ce:given-name": "Apatsara",
                                "preferred-name": {
                                    "ce:given-name": "Apatsara",
                                    "ce:initials": "A.",
                                    "ce:surname": "Treenert",
                                    "ce:indexed-name": "Treenert A."
                                },
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Treenert",
                                "@auid": "57204445606",
                                "ce:indexed-name": "Treenert A."
                            },
                            {
                                "ce:given-name": "Nutthada",
                                "preferred-name": {
                                    "ce:given-name": "Nutthada",
                                    "ce:initials": "N.",
                                    "ce:surname": "Areepium",
                                    "ce:indexed-name": "Areepium N."
                                },
                                "@seq": "2",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Areepium",
                                "@auid": "13610558100",
                                "ce:indexed-name": "Areepium N."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Medical Oncology Unit"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113019942"
                            },
                            "@dptid": "113019942"
                        },
                        "author": [{
                            "ce:given-name": "Suebpong",
                            "preferred-name": {
                                "ce:given-name": "Suebpong",
                                "ce:initials": "S.",
                                "ce:surname": "Tanasanvimon",
                                "ce:indexed-name": "Tanasanvimon S."
                            },
                            "@seq": "3",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tanasanvimon",
                            "@auid": "23089332900",
                            "ce:indexed-name": "Tanasanvimon S."
                        }]
                    }
                ],
                "citation-title": "Effects of ABCC2 and SLCO1B1 Polymorphisms on treatment responses in Thai metastatic colorectal cancer patients treated with Irinotecan-based chemotherapy",
                "abstracts": "Â© 2018, Asian Pacific Organization for Cancer Prevention.Purpose: Irinotecan is an anticancer medicine which is used mostly in metastatic colorectal cancer (mCRC) treatment as second or third line chemotherapy. Several factors affect its efficacy and toxicity, including pharmacogenomics. This study aimed to investigate the impacts of ABCC2 and SLCO1B1 polymorphisms on treatment responses in irinotecan-based chemotherapy in 49 Thai mCRC patients. Materials and Methods: Forty-nine participants with mCRC enrolled in this study received irinotecan-based chemotherapy from January to June 2017. Genotypic analyses of ABCC2 (C > T, rs717620) and SLCO1B1 (A > G, rs2306283) were performed. Treatment responses were evaluated after at least three cycles of chemotherapy were given. Results: Allele frequencies of ABCC2 (C > T) and SLCO1B1 (A > G) were found at 18.37% and 78.57%, respectively. Neither was associated with treatment responses. However, combined genotypes of ABCC2 and SLCO1B1 tended to be associated with clinical benefits in terms of partial responses (PR) and stable disease (SD). All patients (100%) with at least one variant allele of SLCO1B1 and ABCC2 were in a PR or SD group, while patients with other genotypes had progressive disease (PD) at 45.5% to 70%, (p = 0.059). Conclusion: The combined effect of ABCC2 and SLCO1B1 polymorphisms tended to be associated with treatment responses in irinotecan-based treated mCRC patients. Therefore, such polymorphisms could be factors impacting inter-individual variation of irinotecan efficacy in Thai mCRC patients.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Department of Pharmacy Practice"},
                            {"$": "Faculty of Pharmaceutical Sciences"},
                            {"$": "Chulalongkorn University"}
                        ]
                    },
                    "person": {
                        "ce:given-name": "Nutthada",
                        "ce:initials": "N.",
                        "ce:surname": "Areepium",
                        "ce:indexed-name": "Areepium N."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "ABCC2",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Irinotecan",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Metastatic colorectal cancer",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "SLCO1B1",
                            "@xml:lang": "eng"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Asian Pac. J. Cancer Preven.",
                    "website": {"ce:e-address": {
                        "$": "http://journal.waocp.org/article_70489_72108f996ed84e8975e1610f97e26a29.pdf",
                        "@type": "email"
                    }},
                    "@country": "tha",
                    "translated-sourcetitle": {
                        "$": "Asian Pacific Journal of Cancer Prevention",
                        "@xml:lang": "eng"
                    },
                    "issn": [
                        {
                            "$": "2476762X",
                            "@type": "electronic"
                        },
                        {
                            "$": "15137368",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "19",
                            "@issue": "10"
                        },
                        "pagerange": {
                            "@first": "2757",
                            "@last": "2764"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2018"},
                    "publisher": {
                        "publishername": "Asian Pacific Organization for Cancer Prevention",
                        "ce:e-address": {
                            "$": "kyyoo@plaza.snu.ac.kr;",
                            "@type": "email"
                        }
                    },
                    "sourcetitle": "Asian Pacific Journal of Cancer Prevention",
                    "@srcid": "40173",
                    "publicationdate": {
                        "month": "10",
                        "year": "2018",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 October 2018"
                        },
                        "day": "01"
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2713"},
                                {"$": "2730"},
                                {"$": "2739"},
                                {"$": "1306"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "MEDI"},
                                {"$": "BIOC"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": {
                                "cas-registry-number": "100286-90-6",
                                "chemical-name": "irinotecan"
                            }
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Antineoplastic Agents"},
                                {"chemical-name": "Irinotecan"},
                                {"chemical-name": "Liver-Specific Organic Anion Transporter 1"},
                                {"chemical-name": "multidrug resistance-associated protein 2"},
                                {"chemical-name": "Multidrug Resistance-Associated Proteins"},
                                {"chemical-name": "SLCO1B1 protein, human"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "Research grant funds have been provided for this study by the 90th Anniversary Chulalongkorn University Fund (Ratchadapiseksomphot Endowment Fund)",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2018 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "SNEMB"},
                    {"$": "Scopusbase"},
                    {"$": "MEDL"}
                ],
                "history": {"date-created": {
                    "@day": "02",
                    "@year": "2018",
                    "@timestamp": "BST 12:47:06",
                    "@month": "11"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "624693333",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "913642584",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "2018364794",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20181952482",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20183247760",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2018130605",
                            "@idtype": "SNEMB"
                        },
                        {
                            "$": "85055616649",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85055616649",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "624658423",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "30360603",
                            "@idtype": "MEDL"
                        }
                    ],
                    "ce:doi": "10.22034/APJCP.2018.19.10.2757"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "21",
                "reference": [
                    {
                        "ref-fulltext": "Akiyama Y, Fujita K, Ishida H, et al (2012). Association of ABCC2 genotype with efficacy of first-line FOLFIRI in Japanese patients with advanced colorectal cancer. Drug Metab Pharmacokinet, 27, 325-35",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Association of ABCC2 genotype with efficacy of first-line FOLFIRI in Japanese patients with advanced colorectal cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84863199899",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "325",
                                    "@last": "335"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Akiyama",
                                        "ce:indexed-name": "Akiyama Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Fujita",
                                        "ce:indexed-name": "Fujita K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Ishida",
                                        "ce:indexed-name": "Ishida H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Drug Metab Pharmacokinet"
                        }
                    },
                    {
                        "ref-fulltext": "Atasilp C, Chansriwong P, Sirachainan E, et al (2016). Correlation of UGT1A1*28 and *6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients. Drug Metab Pharmacok, 31, 90-4",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Correlation of UGT1A1*28 and *6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84957991755",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "90",
                                    "@last": "94"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Atasilp",
                                        "ce:indexed-name": "Atasilp C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Chansriwong",
                                        "ce:indexed-name": "Chansriwong P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Sirachainan",
                                        "ce:indexed-name": "Sirachainan E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Drug Metab Pharmacok"
                        }
                    },
                    {
                        "ref-fulltext": "Benson AB, Venook AP, Cederquist L, et al (2017). Colon cancer, Version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 15, 370-98",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Colon cancer, Version 1.2017, NCCN clinical practice guidelines in oncology"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85016215716",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "370",
                                    "@last": "398"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Benson",
                                        "ce:indexed-name": "Benson A.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Venook",
                                        "ce:indexed-name": "Venook A.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Cederquist",
                                        "ce:indexed-name": "Cederquist L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Natl Compr Canc Netw"
                        }
                    },
                    {
                        "ref-fulltext": "Colucci G, Gebbia V, Paoletti G, et al (2005). Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. J Clin Oncol, 23, 4866-75",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale"},
                            "refd-itemidlist": {"itemid": {
                                "$": "24644457747",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "4866",
                                    "@last": "4875"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Colucci",
                                        "ce:indexed-name": "Colucci G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Gebbia",
                                        "ce:indexed-name": "Gebbia V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Paoletti",
                                        "ce:indexed-name": "Paoletti G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "De Jong FA, Scott-Horton TJ, Kroetz DL, et al (2007). Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein. Clin Pharmacol Ther, 81, 42-9",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33846012498",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "81"},
                                "pagerange": {
                                    "@first": "42",
                                    "@last": "49"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.A.",
                                        "@_fa": "true",
                                        "ce:surname": "De Jong",
                                        "ce:indexed-name": "De Jong F.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Scott-Horton",
                                        "ce:indexed-name": "Scott-Horton T.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Kroetz",
                                        "ce:indexed-name": "Kroetz D.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacol Ther"
                        }
                    },
                    {
                        "ref-fulltext": "Di Martino MT, Arbitrio M, Leone E, et al (2011). Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study. Cancer Biol Ther, 12, 780-7",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80655141268",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "780",
                                    "@last": "787"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Di Martino",
                                        "ce:indexed-name": "Di Martino M.T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Arbitrio",
                                        "ce:indexed-name": "Arbitrio M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Leone",
                                        "ce:indexed-name": "Leone E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Biol Ther"
                        }
                    },
                    {
                        "ref-fulltext": "Fuchs CS, Moore MR, Harker G, et al (2003). Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer. J Clin Oncol, 21, 807-14",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037364658",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "807",
                                    "@last": "814"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Fuchs",
                                        "ce:indexed-name": "Fuchs C.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Moore",
                                        "ce:indexed-name": "Moore M.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Harker",
                                        "ce:indexed-name": "Harker G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "Fujita K, Nagashima F, Yamamoto W, et al (2008). Association of ATP-binding cassette, sub-family C, number 2 (ABCC2) genotype with pharmacokinetics of irinotecan in Japanese patients with metastatic colorectal cancer treated with irinotecan plus infusional 5-fluorouracil/leucovorin (FOLFIRI). Biol Pharm Bull, 31, 2137-42",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Association of ATP-binding cassette, sub-family C, number 2 (ABCC2) genotype with pharmacokinetics of irinotecan in Japanese patients with metastatic colorectal cancer treated with irinotecan plus infusional 5-fluorouracil/leucovorin (FOLFIRI)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "55549141199",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "2137",
                                    "@last": "2142"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Fujita",
                                        "ce:indexed-name": "Fujita K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Nagashima",
                                        "ce:indexed-name": "Nagashima F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Yamamoto",
                                        "ce:indexed-name": "Yamamoto W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biol Pharm Bull"
                        }
                    },
                    {
                        "ref-fulltext": "Haenisch S, Zimmermann U, Dazert E, et al (2007). Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex. Pharmacogenomics J, 7, 56-65",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33847249931",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "56",
                                    "@last": "65"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Haenisch",
                                        "ce:indexed-name": "Haenisch S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "U.",
                                        "@_fa": "true",
                                        "ce:surname": "Zimmermann",
                                        "ce:indexed-name": "Zimmermann U."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Dazert",
                                        "ce:indexed-name": "Dazert E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacogenomics J"
                        }
                    },
                    {
                        "ref-fulltext": "Han JY, Lim HS, Yoo YK, et al (2007). Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer. Cancer, 110, 138-47.3",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34250825286",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "110"},
                                "pagerange": {
                                    "@first": "138.3",
                                    "@last": "147.3"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Han",
                                        "ce:indexed-name": "Han J.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lim",
                                        "ce:indexed-name": "Lim H.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoo",
                                        "ce:indexed-name": "Yoo Y.K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer"
                        }
                    },
                    {
                        "ref-fulltext": "Hashim D, Boffetta P, La Vecchia C, et al (2016). The global decrease in cancer mortality: trends and disparities. Ann Oncol, 27, 926-33",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "The global decrease in cancer mortality: trends and disparities"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84964766145",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "926",
                                    "@last": "933"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Hashim",
                                        "ce:indexed-name": "Hashim D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Boffetta",
                                        "ce:indexed-name": "Boffetta P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "La Vecchia",
                                        "ce:indexed-name": "La Vecchia C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "Huang L, Zhang T, Xie C, et al (2013). SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer. PLoS One, 8, e77223",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "e77223",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "84885454517",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "8"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Xie",
                                        "ce:indexed-name": "Xie C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        }
                    },
                    {
                        "ref-fulltext": "Innocenti F, Kroetz DL, Schuetz E, et al (2009). Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. J Clin Oncol, 27, 2604-14",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics"},
                            "refd-itemidlist": {"itemid": {
                                "$": "66849111193",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "2604",
                                    "@last": "2614"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Innocenti",
                                        "ce:indexed-name": "Innocenti F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Kroetz",
                                        "ce:indexed-name": "Kroetz D.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Schuetz",
                                        "ce:indexed-name": "Schuetz E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "Liu X, Cheng D, Kuang Q, et al (2014). Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians. Pharmacogenomics J, 14, 120-9",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84897383948",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "120",
                                    "@last": "129"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu X."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Cheng",
                                        "ce:indexed-name": "Cheng D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Kuang",
                                        "ce:indexed-name": "Kuang Q."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacogenomics J"
                        }
                    },
                    {
                        "ref-fulltext": "Minami H, Sai K, Saeki M, et al (2007). Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28. Pharmacogenet Genom, 17, 497-504",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34250202527",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "497",
                                    "@last": "504"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Minami",
                                        "ce:indexed-name": "Minami H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Sai",
                                        "ce:indexed-name": "Sai K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Saeki",
                                        "ce:indexed-name": "Saeki M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacogenet Genom"
                        }
                    },
                    {
                        "ref-fulltext": "Nozawa T, Minami H, Sugiura S, Tsuji A, Tamai I (2005). Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms. Drug Metab Dispos, 33, 434-39",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms"},
                            "refd-itemidlist": {"itemid": {
                                "$": "14044260589",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "434",
                                    "@last": "439"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Nozawa",
                                    "ce:indexed-name": "Nozawa T."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Minami",
                                    "ce:indexed-name": "Minami H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Sugiura",
                                    "ce:indexed-name": "Sugiura S."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Tsuji",
                                    "ce:indexed-name": "Tsuji A."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Tamai",
                                    "ce:indexed-name": "Tamai I."
                                }
                            ]},
                            "ref-sourcetitle": "Drug Metab Dispos"
                        }
                    },
                    {
                        "ref-fulltext": "Phiphatpatthamaamphan K, Vilaichone R (2016). Colorectal cancer in the central region of Thailand. Asian Pac J Cancer Prev, 17, 3647-50",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Colorectal cancer in the central region of Thailand"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84983372709",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "3647",
                                    "@last": "3650"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Phiphatpatthamaamphan",
                                    "ce:indexed-name": "Phiphatpatthamaamphan K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Vilaichone",
                                    "ce:indexed-name": "Vilaichone R."
                                }
                            ]},
                            "ref-sourcetitle": "Asian Pac J Cancer Prev"
                        }
                    },
                    {
                        "ref-fulltext": "Teft WA, Welch S, Lenehan J, et al (2015). OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy. Br J Cancer, 112, 857-65",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84928702607",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "112"},
                                "pagerange": {
                                    "@first": "857",
                                    "@last": "865"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Teft",
                                        "ce:indexed-name": "Teft W.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Welch",
                                        "ce:indexed-name": "Welch S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Lenehan",
                                        "ce:indexed-name": "Lenehan J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Cancer"
                        }
                    },
                    {
                        "ref-fulltext": "Tournigand C, Andre T, Achille E, et al (2004). FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol, 22, 229-37",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "1342290189",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "229",
                                    "@last": "237"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Tournigand",
                                        "ce:indexed-name": "Tournigand C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Andre",
                                        "ce:indexed-name": "Andre T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Achille",
                                        "ce:indexed-name": "Achille E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "Watanabe H, Okada M, Kaji Y, et al (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228-47",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "57849117384",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "228",
                                    "@last": "247"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Watanabe",
                                        "ce:indexed-name": "Watanabe H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Okada",
                                        "ce:indexed-name": "Okada M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Kaji",
                                        "ce:indexed-name": "Kaji Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Cancer"
                        }
                    },
                    {
                        "ref-fulltext": "Zhou Q, Sparreboom A, Tan EH, et al (2005). Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer. Br J Clin Pharmacol, 59, 415-24",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "17144413348",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "59"},
                                "pagerange": {
                                    "@first": "415",
                                    "@last": "424"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou Q."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Sparreboom",
                                        "ce:indexed-name": "Sparreboom A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Tan",
                                        "ce:indexed-name": "Tan E.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Clin Pharmacol"
                        }
                    }
                ]
            }}
        }
    },
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85055616649",
        "dc:description": "Purpose: Irinotecan is an anticancer medicine which is used mostly in metastatic colorectal cancer (mCRC) treatment as second or third line chemotherapy. Several factors affect its efficacy and toxicity, including pharmacogenomics. This study aimed to investigate the impacts of ABCC2 and SLCO1B1 polymorphisms on treatment responses in irinotecan-based chemotherapy in 49 Thai mCRC patients. Materials and Methods: Forty-nine participants with mCRC enrolled in this study received irinotecan-based chemotherapy from January to June 2017. Genotypic analyses of ABCC2 (C > T, rs717620) and SLCO1B1 (A > G, rs2306283) were performed. Treatment responses were evaluated after at least three cycles of chemotherapy were given. Results: Allele frequencies of ABCC2 (C > T) and SLCO1B1 (A > G) were found at 18.37% and 78.57%, respectively. Neither was associated with treatment responses. However, combined genotypes of ABCC2 and SLCO1B1 tended to be associated with clinical benefits in terms of partial responses (PR) and stable disease (SD). All patients (100%) with at least one variant allele of SLCO1B1 and ABCC2 were in a PR or SD group, while patients with other genotypes had progressive disease (PD) at 45.5% to 70%, (p = 0.059). Conclusion: The combined effect of ABCC2 and SLCO1B1 polymorphisms tended to be associated with treatment responses in irinotecan-based treated mCRC patients. Therefore, such polymorphisms could be factors impacting inter-individual variation of irinotecan efficacy in Thai mCRC patients.",
        "pubmed-id": "30360603",
        "prism:coverDate": "2018-10-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85055616649",
        "dc:creator": {"author": [{
            "ce:given-name": "Apatsara",
            "preferred-name": {
                "ce:given-name": "Apatsara",
                "ce:initials": "A.",
                "ce:surname": "Treenert",
                "ce:indexed-name": "Treenert A."
            },
            "@seq": "1",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Treenert",
            "@auid": "57204445606",
            "author-url": "https://api.elsevier.com/content/author/author_id/57204445606",
            "ce:indexed-name": "Treenert A."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85055616649"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85055616649&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85055616649&origin=inward"
            }
        ],
        "source-id": "40173",
        "citedby-count": "9",
        "prism:volume": "19",
        "subtype": "ar",
        "dc:title": "Effects of ABCC2 and SLCO1B1 Polymorphisms on treatment responses in Thai metastatic colorectal cancer patients treated with Irinotecan-based chemotherapy",
        "openaccess": null,
        "prism:issn": "2476762X 15137368",
        "publishercopyright": "Â© 2018, Asian Pacific Organization for Cancer Prevention.",
        "prism:issueIdentifier": "10",
        "subtypeDescription": "Article",
        "prism:publicationName": "Asian Pacific Journal of Cancer Prevention",
        "prism:pageRange": "2757-2764",
        "prism:endingPage": "2764",
        "openaccessFlag": null,
        "prism:doi": "10.22034/APJCP.2018.19.10.2757",
        "prism:startingPage": "2757",
        "dc:identifier": "SCOPUS_ID:85055616649",
        "dc:publisher": "Asian Pacific Organization for Cancer Preventionkyyoo@plaza.snu.ac.kr;"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Alleles",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antineoplastic Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Colorectal Neoplasms",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Gene Frequency",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Irinotecan",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Liver-Specific Organic Anion Transporter 1",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Multidrug Resistance-Associated Proteins",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Polymorphism, Single Nucleotide",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Prospective Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thailand",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Treatment Outcome",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "ABCC2"
        },
        {
            "@_fa": "true",
            "$": "Irinotecan"
        },
        {
            "@_fa": "true",
            "$": "Metastatic colorectal cancer"
        },
        {
            "@_fa": "true",
            "$": "SLCO1B1"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Apatsara",
            "preferred-name": {
                "ce:given-name": "Apatsara",
                "ce:initials": "A.",
                "ce:surname": "Treenert",
                "ce:indexed-name": "Treenert A."
            },
            "@seq": "1",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Treenert",
            "@auid": "57204445606",
            "author-url": "https://api.elsevier.com/content/author/author_id/57204445606",
            "ce:indexed-name": "Treenert A."
        },
        {
            "ce:given-name": "Nutthada",
            "preferred-name": {
                "ce:given-name": "Nutthada",
                "ce:initials": "N.",
                "ce:surname": "Areepium",
                "ce:indexed-name": "Areepium N."
            },
            "@seq": "2",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Areepium",
            "@auid": "13610558100",
            "author-url": "https://api.elsevier.com/content/author/author_id/13610558100",
            "ce:indexed-name": "Areepium N."
        },
        {
            "ce:given-name": "Suebpong",
            "preferred-name": {
                "ce:given-name": "Suebpong",
                "ce:initials": "S.",
                "ce:surname": "Tanasanvimon",
                "ce:indexed-name": "Tanasanvimon S."
            },
            "@seq": "3",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Tanasanvimon",
            "@auid": "23089332900",
            "author-url": "https://api.elsevier.com/content/author/author_id/23089332900",
            "ce:indexed-name": "Tanasanvimon S."
        }
    ]}
}}